Announcement PDF Appendix 3Y Change of Director’s Interest Notice Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity IMAGION BIOSYSTEMS LIMITED ABN 42 616 305 027 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Mark VAN ASTEN Date of last notice 27 June 2019 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct Nature of indirect interest (including registered holder) N/A Note: Provide details of the circumstances giving rise to the relevant interest. Date of change 26 November 2019 No. of securities held prior to change 1) 150,000 Shares 2) 50,000 Performance Rights issued under the Company’s ISO, and automatically vesting into Shares on a one-for one basis on the vesting date, being 6 June 2020. 3) Nil Listed Options (exercisable at $0.05 on or before 26 November 2019) 1) Fully Paid Ordinary Shares (Shares) 2) Performance Rights 3) Listed Options Class Number acquired + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 1) 150,000 Shares 2) Nil Performance Rights 3) 75,000 Listed Options Appendix 3Y Change of Director’s Interest Notice Number disposed 1) Nil Fully Paid Ordinary Shares 2) Nil Performance Rights 3) Nil Listed Options Value/Consideration 1) 0.02 per Share 2) N/A Performance Rights 3) Nil consideration for Listed Options Note: If consideration is non-cash, provide details and estimated valuation No. of securities held after change 1) 300,000 Shares 2) 50,000 Performance Rights 3) 75,000 Listed Options Nature of change Subscription of full entitlement under the Company’s rights offer as announced on 28 October 2019. Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest N/A Name of registered holder (if issued securities) Date of change N/A No. and class of securities to which interest related prior to change N/A N/A Note: Details are only required for a contract in relation to which the interest has changed Interest acquired N/A Interest disposed N/A Value/Consideration N/A Note: If consideration is non-cash, provide details and an estimated valuation Interest after change N/A Part 3 – +Closed period Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? No If prior written clearance was provided, on what date was this provided? N/A N/A + See chapter 19 for defined terms. Appendix 3Y Page 2 01/01/2011